plerixafor has been researched along with Osteoarthritis, Knee in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Fleming, BC; Li, G; Li, P; Thomas, NP; Wei, L; Wei, X; Xiao-Hua, P | 1 |
| Chen, Y; Guo, J; Ho, KW; Li, G; Lin, S; Lu, Y; Pan, X; Suen, CW; Sun, Y; Zha, Z; Zhang, J | 1 |
2 other study(ies) available for plerixafor and Osteoarthritis, Knee
| Article | Year |
|---|---|
Attenuation of cartilage pathogenesis in post-traumatic osteoarthritis (PTOA) in mice by blocking the stromal derived factor 1 receptor (CXCR4) with the specific inhibitor, AMD3100.
Topics: Animals; Benzylamines; Cartilage, Articular; Cyclams; Drug Evaluation, Preclinical; Fluorescent Dyes; Heterocyclic Compounds; Immunohistochemistry; Knee Injuries; Male; Mice, Inbred C57BL; Osteoarthritis, Knee; Random Allocation; Receptors, CXCR4; Tomography | 2015 |
Attenuation of subchondral bone abnormal changes in osteoarthritis by inhibition of SDF-1 signaling.
Topics: Aged; Animals; Anterior Cruciate Ligament; Anterior Cruciate Ligament Injuries; Benzylamines; Bone and Bones; Cell Differentiation; Chemokine CXCL12; Cyclams; Female; Heterocyclic Compounds; Humans; Knee Joint; Male; Menisci, Tibial; Mesenchymal Stem Cells; Middle Aged; Osteoarthritis, Knee; Osteogenesis; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; Tibial Meniscus Injuries; X-Ray Microtomography | 2017 |